Meet in Italy for Life Sciences Brokerage Event 2026

13 – 14 Oct 2026 | Roma, Italy

NANOX RELEASE TECHNOLOGY

Company/Start-up

nanoxrelease.com/contact/Buenos Aires, Argentina
11 profile visits

About

Nanox is a fully integrated nano-biotechnology company dedicated to the research, development, testing and commercialization of advanced nano-pharmaceutical drugs — a true one-stop-shop built on four proprietary platforms: a) liposomes (Base of Anfonax / Anfotar and Irinax) b) nanoparticles (Base of Paclinax); c) microspheres (Base of Leupronax / Octreonax))and nanomicelles (nobel technology for delivery of active ingredients ). Behind its first proprietary product on the market lie more than ten years of work in R&D and regulatory management. While its commercial focus today is on the human pharmaceutical industry, these four platforms have potential applications in other industries —such as agrochemicals, cosmetics, animal medicines and nutritional food — extending the reach of the Company's technology beyond its current use.

Areas of activity

Life Science Domain

PharmaResearch

Pharma

Drug delivery systemsSmall molecules & APIs

Research

Nanomedicine & biomaterials

Representatives

CEO NANOX RELEASE

NANOX RELEASE TECHNOLOGY